Publications (original articles or review articles) published in 2021 from OUS - Section for Preventive Cardiology
6 publications found
Long-term effects (> 24 months) of multiple lifestyle intervention on major cardiovascular risk factors among high-risk subjects: a meta-analysis
BMC Cardiovasc Disord, 21 (1), 181
DOI 10.1186/s12872-021-01989-5, PubMed 33858345
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial
JAMA Cardiol, 6 (2), 139-147
DOI 10.1001/jamacardio.2020.3151, PubMed 32785614
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial
Circ J, 85 (11), 2063-2070
DOI 10.1253/circj.CJ-20-1051, PubMed 33980763
Cue restricted smoking increases quit rates with varenicline
Tob Prev Cessat, 7, 33
DOI 10.18332/tpc/133570, PubMed 34017927
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
Atherosclerosis, 320, 1-9
DOI 10.1016/j.atherosclerosis.2021.01.003, PubMed 33497862
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur Heart J, 42 (34), 3227-3337
DOI 10.1093/eurheartj/ehab484, PubMed 34458905